Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine A McQuerry

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Translational Oncology|July 23, 2021
Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1Jasmine A McQuerry, Jinfeng Chen, Jeffrey T Chang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 6, 2017
Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypesJasmine A McQuerry, Jeffrey T Chang, David D L Bowtell, et al.
Seminars in Cell & Developmental Biology|June 25, 2016
The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersGajendra Shrestha, Shelley M MacNeil, Jasmine A McQuerry, et al.
Scientific Reports|May 9, 2022
Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patientsJasmine A McQuerry, Merry Mclaird, Samantha N Hartin, et al.
BMC Cancer|September 7, 2019
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypesJasmine A McQuerry, David F Jenkins, Susan E Yost, et al.
Translational Oncology|November 22, 2020
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancerFeng Chi, Jiayi Liu, Samuel W Brady, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Genome Medicine|October 29, 2021
Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsiesXiaomeng Huang, Yi Qiao, Samuel W Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapyJason I Griffiths, Pierre Wallet, Lance T Pflieger, et al.
Future Science OA|January 13, 2021
Co-stimulatory and co-inhibitory immune markers in solid tumors with <i>MET</i> alterationsKaren L Reckamp, Jasmine A McQuerry, Isa Mambetsariev, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Translational Oncology|July 23, 2021
Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1Jasmine A McQuerry, Jinfeng Chen, Jeffrey T Chang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 6, 2017
Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypesJasmine A McQuerry, Jeffrey T Chang, David D L Bowtell, et al.
Seminars in Cell & Developmental Biology|June 25, 2016
The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersGajendra Shrestha, Shelley M MacNeil, Jasmine A McQuerry, et al.
Scientific Reports|May 9, 2022
Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patientsJasmine A McQuerry, Merry Mclaird, Samantha N Hartin, et al.
BMC Cancer|September 7, 2019
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypesJasmine A McQuerry, David F Jenkins, Susan E Yost, et al.
Translational Oncology|November 22, 2020
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancerFeng Chi, Jiayi Liu, Samuel W Brady, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Genome Medicine|October 29, 2021
Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsiesXiaomeng Huang, Yi Qiao, Samuel W Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapyJason I Griffiths, Pierre Wallet, Lance T Pflieger, et al.
Future Science OA|January 13, 2021
Co-stimulatory and co-inhibitory immune markers in solid tumors with <i>MET</i> alterationsKaren L Reckamp, Jasmine A McQuerry, Isa Mambetsariev, et al.
Pageof 2